Pradžia › Fenilketonurija › Texas
Fenilketonurija klinikiniai tyrimai Texas
7 tyrimai dėl Fenilketonurija ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
- University of Texas Southwestern Medical Center (UTSW), Dallas
Renkami dalyviai1 fazė
Amžius nuo 18 iki 69 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07241234AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
- University or Texas, Southwestern medical Center, Dallas
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-08-18 · NCT06332807A Study of JNT-517 in Participants With Phenylketonuria (PKU)
- University of Texas Southwestern, Dallas
- University of Texas Health (UTHealth) Science Center at Houston, Houston
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-08 · NCT06971731Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
- UT Southwestern Medical Center, Dallas
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-17 · NCT07477691A Long-Term Study of JNT-517 in Participants With Phenylketonuria
- Children's Medical Center Dallas, Dallas
- University of Texas Southwestern Medical Center, Dallas
- University of Texas Health (UTHealth) Science Center at Houston, Houston
Renkami dalyviai3 fazė
Amžius 4 ir vyresni · Visoms lytims · Atnaujinta 2026-05-01 · NCT06628128A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
- University of Texas Southwestern Medical Center, Dallas
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-03-25 · NCT05813678A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
- UT Southwestern Medical Center, Dallas
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-03-24 · NCT06305234Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.